Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002723024 | SCV003561178 | uncertain significance | Inborn genetic diseases | 2021-07-13 | criteria provided, single submitter | clinical testing | The c.3229A>G (p.T1077A) alteration is located in exon 17 (coding exon 17) of the MED13L gene. This alteration results from a A to G substitution at nucleotide position 3229, causing the threonine (T) at amino acid position 1077 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |